This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

2024 ASCO® Annual Meeting Insights Hub
T

ASCO® 2024 Insights: "Glofitamab Monotherapy in Patients With Heavily Pretreated R/R MCL"

By 2024 ASCO® Annual Meeting Insights Hub FEATURING Tycel Phillips
By 2024 ASCO® Annual Meeting Insights Hub FEATURING Tycel Phillips
51 views
June 25, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

37:21
Amgen Sponsorship

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

2024 ASCO® Annual Meeting Insights Hub: Hematologic Oncology Videos

06:26
ecancer

Post-Transplant Cyclophosphamide Based GVHD Prophylaxis in Patients …

Feat. M. Al Malki, S. Devine
09:04
ecancer

ASCO® 2024 Insights: "Importance of MRD in Newly Diagnosed Mult…

Feat. X. Leleu
27:49
Insights from 2024 EHA Annual Meeting

AML, MDS, and CML Highlights & Key Takeaways From ASCO®/EHA 2024

Feat. T. Badar
View All

Related Content

AUTOPLAY
16:57
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Lymphoma Highlights"

Feat. B. D. Cheson
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
16:34
Jennifer Amengual

Top 5 Lymphoma Abstracts From ASH

18:24
Memorial Sloan Kettering Cancer Center

Key Lymphoma Updates From ASH

Feat. P. Torka
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
10:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…

Feat. J. DiPersio
25:23
Indy Hematology Review

When Not to Watch and Wait: Emerging Strategies in the Treatment of …

Feat. M. Williams
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
14:34
Northwestern Medicine Oncology and Hematology

EZH2 Inhibition in FL: Overview and Analysis of the SYMPHONY-1 Trial

Feat. L. Gordon
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
04:34
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Highlights and Key Takeaways in MCL"

Feat. P. Jain
22:38
Indy Hematology Review

Immune Effector Cell Therapy for Lymphoid Malignancies: What to Do a…

Feat. T. Phillips
18:50
MyCancerHaven

CLL and MCL: Experts Discuss the Use of Pirtobrutinib

Feat. R. Vij, G. Shouse
16:05
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: What Is High Risk MCL and How Should We Treat It

Feat. A. Kumar
15:18
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Practical Updates on Advances in CLL and MCL

Feat. E. Chong
06:43
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MCL - Highlights & Key Takea…

Feat. V. Yazbeck
13:58
Insights from 2024 EHA Annual Meeting

EHA 2024 Insights: Intrathecal Rituximab + Dex for Refractory Sanctu…

Feat. M. Salamoon
07:22
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Hypertension in Pts With CLL and Other Heme…

Feat. A. Ferrajoli
34:11
SOHO Highlights: State of the Art and Next Questions

State of the Art and Next Questions: Management of MCL

Feat. A. Goy